Home LiteratureArticle Details
PMID: 6262157 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Antigenic structure of poliovirus.

Developments in biological standardization ·Vol. 47 ·1981-00-00 ·Pages 319-33

Dernick R

Abstract

The molecular basis for future developments of poliovirus vaccines is the detailed knowledge of the structure of the virion. Different types and forms of poliovirus particles are detected in virus preparations. Physical and chemical properties characterize the virion better than its electron microscopic image. The compact poliovirus particle is dissociated only by strong denaturizing agents into four polypeptides and RNA. The best analytical method to separate and characterize these polypeptides is the two-dimensional gel electrophoresis. Isoelectric focusing in urea sucrose gradients gives excellent separations also on a preparative scale. The antigenicity of poliovirus particles is the consequence of a complex cleavage pathway leading from the originally translated polyprotein to virus particles. Bearing in mind the need for a special conformation of the virus protein for N-antigenicity, ways are discussed of how to produce a non-infectious poliovirus vaccine in the future.

MeSH Terms
Antigens, Viral Peptides/immunology Poliovirus/immunology Protein Conformation Viral Proteins/immunology Virion/ultrastructure
Chemicals
Antigens, Viral Peptides Viral Proteins
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Dernick R
Article Info
Journal
Developments in biological standardization
Abbr.
Dev Biol Stand
ISSN
0301-5149
Published
1981-00-00
Pages
319-33
Language
English
Region
Switzerland
NLM ID
0427140
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com